Document is current

Any future updates will be listed below

1087 SOT201 is a novel cis-acting immunocytokine targeting IL-15Rβγ to reinvigorate PD-1<sup>+</sup>tumor infiltrating lymphocytes and potentiate anti-tumor efficacy

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.1087

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark